Abstract | BACKGROUND: The risk for patients with primary brain tumors of experiencing an epileptic seizure at least once in the course of disease probably exceeds 50%, depending on tumor location and tumor type. Several aspects regarding the role of anticonvulsants in the treatment of brain tumor patients have remained controversial. PATIENTS AND METHODS: RESULTS: The overall seizure incidence was 68%. Pre-operative seizures did not predict the occurrence of post-operative seizures. After surgery, postoperative chemo- or radiotherapy and anticonvulsive therapy one third of patients was seizure-free whereas one third showed frequent seizures despite this treatment. Seizure frequency increased regardless of anticonvulsive treatment with progressive or recurrent tumor growth. CONCLUSIONS: Based on a literature review and our institutional experience, we delineate some recommendations for the management of seizures in patients with brain tumors.
|
Authors | Wolfgang Wick, Oliver Menn, Christoph Meisner, Joachim Steinbach, Mirjam Hermisson, Marcos Tatagiba, Michael Weller |
Journal | Onkologie
(Onkologie)
Vol. 28
Issue 8-9
Pg. 391-6
(Aug 2005)
ISSN: 0378-584X [Print] Switzerland |
PMID | 16160401
(Publication Type: Journal Article)
|
Chemical References |
- Anticonvulsants
- Antineoplastic Agents
|
Topics |
- Adolescent
- Adult
- Aged
- Anticonvulsants
(administration & dosage, adverse effects)
- Antineoplastic Agents
(administration & dosage, adverse effects)
- Brain Neoplasms
(complications, diagnosis, drug therapy, surgery)
- Cerebral Cortex
(drug effects, surgery)
- Chemotherapy, Adjuvant
- Combined Modality Therapy
- Disease Progression
- Drug Interactions
- Epilepsies, Partial
(drug therapy, etiology)
- Female
- Glioma
(complications, diagnosis, drug therapy, surgery)
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(complications, diagnosis)
- Retrospective Studies
|